SP
Shitla Prasad Upadhyay
About Shitla Prasad Upadhyay
Data last updated:
Shitla Prasad Upadhyay is an Additional Director at Sahid Khudiram Bose Hospital (since 2025) and Director at Cure And Care Polyclinic And Pathology Private Limited (since 2021). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹14.99 Cr; the largest is Sahid Khudiram Bose Hospital at ₹14.96 Cr (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 01 Jun 2025 | 2014 | ₹14.96 Cr (FY 2022) | Active | |
| Director | 11 Oct 2021 | 2021 | ₹2.9 Lakh (FY 2024) | Active |
Board colleagues of Shitla Prasad Upadhyay
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ashis Kumar Saha | 00749992 | Sahid Khudiram Bose Hospital | Director |
| Govinda Ganguly | 06679482 | Sahid Khudiram Bose Hospital | Director |
| Hemanta Kumar Ray | 07693147 | Sahid Khudiram Bose Hospital | Director |
| Subrata Dasgupta | 06679499 | Sahid Khudiram Bose Hospital | Director |
| Suprieo Bhadra | 09512536 | Sahid Khudiram Bose Hospital | Director |
| Rajnish Kumar Upadhyay | 09352705 | Cure And Care Polyclinic And Pathology Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shitla Prasad Upadhyay
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shitla Prasad Upadhyay
Shitla Prasad Upadhyay currently holds 2 directorships: Sahid Khudiram Bose Hospital (Additional Director, since 01 Jun 2025, revenue ₹14.96 Cr (FY 2022)); Cure And Care Polyclinic And Pathology Private Limited (Director, since 11 Oct 2021, revenue ₹2.9 Lakh (FY 2024)).
Shitla Prasad Upadhyay was first appointed on 11 Oct 2021 as Director at Cure And Care Polyclinic And Pathology Private Limited. The most recent appointment on record is 01 Jun 2025 at Sahid Khudiram Bose Hospital.
The 2 current companies of Shitla Prasad Upadhyay that report revenue have a combined latest revenue of ₹14.99 Cr: Sahid Khudiram Bose Hospital ₹14.96 Cr (FY 2022); Cure And Care Polyclinic And Pathology Private Limited ₹2.9 Lakh (FY 2024).
The current boards of Shitla Prasad Upadhyay's companies include Ashis Kumar Saha (Sahid Khudiram Bose Hospital), Govinda Ganguly (Sahid Khudiram Bose Hospital), Hemanta Kumar Ray (Sahid Khudiram Bose Hospital), Subrata Dasgupta (Sahid Khudiram Bose Hospital), Suprieo Bhadra (Sahid Khudiram Bose Hospital), Rajnish Kumar Upadhyay (Cure And Care Polyclinic And Pathology Private Limited).